Genome-wide association study of bipolar disorder accounting for effect of body mass index identifies a new risk allele in TCF7L2

Molecular Psychiatry

Volumn 19, Issue 9, 2014, Pages 1010-1016

  Winham, S J ^a   Cuellar Barboza, A B ^a,b   Oliveros, A ^c   McElroy, S L ^d,e   Crow, S ^f   Colby, C ^a   Choi, D S ^a,c   Chauhan, M ^g   Frye, M ^a   Biernacka, J M ^a  

^a MAYO CLINIC ROCHESTER   (United States)

^b UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^c MAYO GRADUATE SCHOOL   (United States)

^d LINDNER CENTER OF HOPE   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g MAYO CLINIC   (United States)

Author keywords

bipolar disorder; body mass index; genome wide association study; interaction; network analysis

Indexed keywords

OXIDOREDUCTASE; PROTEIN; PROTEIN MCTP2; PROTEIN SEPHS1P2; SPACER DNA; TRANSCRIPTION FACTOR 7 LIKE 2; UNCLASSIFIED DRUG; TCF7L2 PROTEIN, HUMAN;

ARTICLE; BIPOLAR DISORDER; BODY MASS; CONTROLLED STUDY; DEPRESSION; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSEUDOGENE; SINGLE NUCLEOTIDE POLYMORPHISM; WNT SIGNALING PATHWAY; AFRICAN AMERICAN; CAUCASIAN; GENETIC PREDISPOSITION; GENETICS; QUESTIONNAIRE; STATISTICAL MODEL;

AFRICAN AMERICANS; BIPOLAR DISORDER; BODY MASS INDEX; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LOGISTIC MODELS; POLYMORPHISM, SINGLE NUCLEOTIDE; QUESTIONNAIRES; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 84927178732     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2013.159     Document Type: Article

References (52)

1. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009; 373: 234-239.
2. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 2003; 60: 497-502.
3. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447: 661-678.
4. Smith EN, Bloss CS, Badner JA, Barrett T, Belmonte PL, Berrettini W et al. Genomewide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry 2009; 14: 755-763.
5. Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008; 40: 1056-1058.
6. Psychiatric GWAS Consortium Bipolar Disorder Working Group. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 2011; 43: 977-983.
7. Rzhetsky A, Wajngurt D, Park N, Zheng T. Probing genetic overlap among complex human phenotypes. Proc Natl Acad Sci USA 2007; 104: 11694-11699.
8. Sicras A, Rejas J, Navarro R, Serrat J, Blanca M. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database. Bipolar Disord 2008; 10: 607-616.
9. Cerimele JM, Katon WJ. Associations between health risk behaviors and symptoms of schizophrenia and bipolar disorder: a systematic review. Gen Hosp Psychiatry 2012; 35: 16-22.
10. McElroy SL, Keck PE Jr. Obesity in bipolar disorder: An overview. Curr Psychiatry Rep 2012; 14: 650-658.
11. McElroy SL, Kotwal R, Malhotra S, Nelson EB, Keck PE, Nemeroff CB. Are mood disorders and obesity related? A review for the mental health professional. J Clin Psychiatry 2004; 65: 634-651, quiz 730.
12. McElroy SL, Crow S, Biernacka JM, Winham S, Geske J, Barboza AB et al. Clinical phenotype of bipolar disorder with comorbid binge eating disorder. J Affect Disord 2013; 150: 981-986.
13. Yang J, Ferreira T, Morris AP, Medland SE, Madden PA, Heath AC et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat Genet 2012; 44: 369-375.
14. Lopresti AL, Drummond PD. Obesity and psychiatric disorders: Commonalities in dysregulated biological pathways and their implications for treatment. Prog Neuropsychopharmacol Biol Psychiatry 2013; 45C: 92-99.
15. Kessler RC, Berglund PA, Chiu WT, Deitz AC, Hudson JI, Shahly V et al. The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health Surveys. Biol Psychiatry 2013; 73: 904-914.
16. Timpson NJ, Lindgren CM, Weedon MN, Randall J, Ouwehand WH, Strachan DP et al. Adiposity-related heterogeneity in patterns of type 2 diabetes susceptibility observed in genome-wide association data. Diabetes 2009; 58: 505-510.
17. Manning AK, Hivert M-F, Scott RA, Grimsby JL, Bouatia-Naji N, Chen H et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet 2012; 44: 659-681.
18. Wang X, Ding X, Su S, Spector TD, Mangino M, Iliadou A et al. Heritability of insulin sensitivity and lipid profile depend on BMI: evidence for gene-obesity interaction. Diabetologia 2009; 52: 2578-2584.
19. Mailman MD, Feolo M, Jin Y, Kimura M, Tryka K, Bagoutdinov R et al. The NCBI dbGaP database of genotypes and phenotypes. Nat Genet 2007; 39: 1181-1186.
20. Kraft P, Yen YC, Stram DO, Morrison J, Gauderman WJ. Exploiting gene-environment interaction to detect genetic associations. Hum Hered 2007; 63: 111-119.
21. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904-909.
22. Delaneau O, Zagury JF, Marchini J. Improved whole-chromosome phasing for disease and population genetic studies. Nat Methods 2013; 10: 5-6.
23. Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet 2012; 44: 955-959.
24. Jin T, Liu L. The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus. Mol Endocrinol 2008; 22: 2383-2392.
25. Saxena R, Elbers CC, Guo Y, Peter I, Gaunt TR, Mega JL et al. Large-scale genecentric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet 2012; 90: 410-425.
26. Nobrega MA. TCF7L2 and Glucose Metabolism: Time to Look Beyond the Pancreas. Diabetes 2013; 62: 706-708.
27. Behrens J, vonKries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R et al. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 1996; 382: 638-642.
28. Cadigan KM, Waterman ML. TCF/LEFs and Wnt signaling in the Nucleus. Cold Spring Harb Perspect Biol 2012; 4: a007906.
29. Saito-Diaz K, Chen TW, Wang XX, Thorne CA, Wallace HA, Page-McCaw A et al. The way Wnt works: Components and mechanism. Growth Factors 2013; 31: 1-31.
30. Budnik V, Salinas PC. Wnt signaling during synaptic development and plasticity. Curr Opin Neurobiol 2011; 21: 151-159.
31. Jang MH, Bonaguidi MA, Kitabatake Y, Sun J, Song J, Kang E et al. Secreted frizzled-related protein 3 regulates activity-dependent adult hippocampal neurogenesis. Cell Stem Cell 2013; 12: 215-223.
32. Seib DR, Corsini NS, Ellwanger K, Plaas C, Mateos A, Pitzer C et al. Loss of Dickkopf-1 restores neurogenesis in old age and counteracts cognitive decline. Cell Stem Cell 2013; 12: 204-214.
33. Wexler EM, Geschwind DH, Palmer TD. Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation. Mol Psychiatry 2008; 13: 285-292.
34. Valvezan AJ, Klein PS. GSK-3 and Wnt Signaling in Neurogenesis and Bipolar Disorder. Front Mol Neurosci 2012; 5: 1.
35. Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 1996; 93: 8455-8459.
36. O'Brien WT, Harper AD, Jove F, Woodgett JR, Maretto S, Piccolo S et al. Glycogen synthase kinase-3 beta haploinsufficiency mimics the behavioral and molecular effects of lithium. J Neurosci 2004; 24: 6791-6798.
37. Zhang F, Phiel CJ, Spece L, Gurvich N, Klein PS. Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium - Evidence for autoregulation of GSK-3. J Biol Chem 2003; 278: 33067-33077.
38. O'Brien WT, Huang J, Buccafusca R, Garskof J, Valvezan AJ, Berry GT et al. Glycogen synthase kinase-3 is essential for beta-arrestin-2 complex formation and lithium-sensitive behaviors in mice. J Clin Invest 2011; 121: 3756-3762.
39. Beaulieu JM, Marion S, Rodriguiz RM, Medvedev IO, Sotnikova TD, Ghisi V et al. A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell 2008; 132: 125-136.
40. Gould TD, Einat H, O'Donnell KC, Picchini AM, Schloesser RJ, Manji HK. Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive Behaviors. Neuropsychopharmacology 2007; 32: 2173-2183.
41. Zhou R, Yuan P, Wang Y, Hunsberger JG, Elkahloun A, Wei Y et al. Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology 2009; 34: 1395-1405.
42. Brennand KJ, Simone A, Jou J, Gelboin-Burkhart C, Tran N, Sangar S et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011; 473: 221-225.
43. Voleti B, Duman RS. The roles of neurotrophic factor and Wnt signaling in depression. Clin Pharmacol Ther 2012; 91: 333-338.
44. Gottardi CJ, Wong E, Gumbiner BM. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J Cell Biol 2001; 153: 1049-1059.
45. Heuberger J, Birchmeier W. Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb Perspect Biol 2010; 2: a002915.
46. Blair IP, Chetcuti AF, Badenhop RF, Scimone A, Moses MJ, Adams LJ et al. Positional cloning, association analysis and expression studies provide convergent evidence that the cadherin gene FAT contains a bipolar disorder susceptibility allele. Mol Psychiatry 2006; 11: 372-383.
47. Soronen P, Ollila HM, Antila M, Silander K, Palo OM, Kieseppa T et al. Replication of GWAS of bipolar disorder: association of SNPs near CDH7 with bipolar disorder and visual processing. Mol Psychiatry 2010; 15: 4-6.
48. Lydall GJ, Bass NJ, McQuillin A, Lawrence J, Anjorin A, Kandaswamy R et al. Confirmation of prior evidence of genetic susceptibility to alcoholism in a genome-wide association study of comorbid alcoholism and bipolar disorder. Psychiatr Genet 2011; 21: 294-306.
49. Redies C, Hertel N, Hubner CA. Cadherins and neuropsychiatric disorders. Brain Res 2012; 1470: 130-144.
50. Cichon S, Muhleisen TW, Degenhardt FA, Mattheisen M, Miro X, Strohmaier J et al. Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet 2011; 88: 372-381.
51. Del Mare S, Salah Z, Aqeilan RI. WWOX: Its Genomics, Partners, and Functions. J Cell Biochem 2009; 108: 737-745.
52. Bouteille N, Driouch K, Hage PE, Sin S, Formstecher E, Camonis J et al. Inhibition of the Wnt/beta-catenin pathway by the WWOX tumor suppressor protein. Oncogene 2009; 28: 2569-2580.